-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$76.13166.47% Upside
Recent Analyst Forecasts and Stock Ratings
Apellis Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. has been rated by research analysts at Robert W. Baird, Stifel Nicolaus, Mizuho Securities, Jefferies, H.C. Wainwright, Wells Fargo in the past 90 days.